š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
As a new dual receptor (integrin Ī±vĪ²3 and FAP) targeting PET radiotracer, 6...
Status
Completed
Location
The First Affiliated Hospital of Xiamen University
Start Date
2022-07-01
Trial ID
NCT05543317
Treatments Being Tested
Intestinal stricture is a complication of Crohn's disease (CD), which is th...
Status
Unknown
Location
Multiple Locations
Start Date
2020-09
Trial ID
NCT04502303
Treatments Being Tested
This study aims to explore the value of 68Ga-FAPI PET/CT in the diagnosis o...
Status
Unknown
Location
Department of Gastric Surgery
Start Date
2021-03
Trial ID
NCT04778345
Treatments Being Tested
To evaluate the potential usefulness of 18F-AlF-FAPI positron emission tomo...
Status
Completed
Location
The First affiliated hospital of xiamen university
Start Date
2022-06-01
Trial ID
NCT05430841
Treatments Being Tested
To evaluate the normal physiological distribution of positron nuclide label...
Status
Unknown
Location
Peking University Cancer Hospital
Start Date
2019-10-16
Trial ID
NCT04750772
Treatments Being Tested
Invasive squamous cell carcinoma (ISCC) represents 5 to 15% of breast cance...
Status
Not Yet Recruiting
Location
Lyon sud Hospital center - Hospices Civils de Lyon
Start Date
2026-03-30
Trial ID
NCT07313033
Treatments Being Tested
68Ga-FAPI has been developed as a tumor-targeting agent as fibroblast activ...
Status
Unknown
Location
Chinese Academy of Medical Sciences & Peking Union Medical College
Start Date
2022-11-01
Trial ID
NCT05686876
Treatments Being Tested
Heart scarring, also known as fibrosis, plays a major role in a lot of hear...
Status
Recruiting
Location
University of Edinburgh
Start Date
2023-05-01
Trial ID
NCT06409585
Treatments Being Tested
Positron emission tomography (PET) molecular imaging provides a valuable to...
Status
Unknown
Location
China, Hubei Province
Start Date
2020-05-22
Trial ID
NCT04554719
Treatments Being Tested